Related Experiment Video
Updated: Jul 22, 2026

State of the Art Cranial Ultrasound Imaging in Neonates
Published on: February 2, 2015
Congenital malformations surveillance: two American systems
Insights
The Centers for Disease Control (CDC) uses two surveillance systems to monitor birth defects nationwide and in Atlanta. These systems help detect potential epidemics and aid epidemiological studies of congenital malformations.
Area of Science:
- Epidemiology
- Public Health
- Genetics
Background:
- Congenital malformations pose a significant public health concern.
- Effective surveillance is crucial for understanding birth defect patterns and causes.
- Historical events, like thalidomide exposure, highlight the need for robust monitoring systems.
Purpose of the Study:
- To describe the Centers for Disease Control's (CDC) two primary birth defect surveillance systems.
- To outline the methodologies employed by these systems for identifying congenital malformations.
- To emphasize the utility of these systems beyond mere monitoring, including epidemiological research.
Main Methods:
- Metropolitan Atlanta Congenital Defects Programme (MACDP): Intensive surveillance using multiple methods in Atlanta.
- Birth Defects Monitoring Programme (BDMP): Nationwide monitoring of 1 million births annually via newborn discharge summaries.
- Both systems are designed for early detection of potential birth defect clusters.
Main Results:
- The MACDP provides in-depth data for a specific geographic area.
- The BDMP offers broad, national-level data on birth defect occurrences.
- These surveillance systems have proven valuable for epidemiological research into birth defects.
Conclusions:
- The CDC's dual approach to birth defect surveillance provides comprehensive data for public health.
- These systems are essential tools for identifying trends and potential environmental or genetic factors in congenital malformations.
- Continued operation and research utilizing these surveillance programs are vital for protecting infant health.
Abstract:
As part of its epidemiologic studies of congenital malformations, the Centers for Disease Control (CDC) conducts two birth defects surveillance systems in the United States. The Metropolitan Atlanta Congenital Defects Programme (MACDP) is an intensive surveillance system using several methods to identify infants born with birth defects in the Atlanta area. The Birth Defects Monitoring Programme (BDMP) is a nationwide surveillance system that monitors 1 million births per year, about a third of all births in the U.S. It relies on diagnoses from newborn discharge summaries to ascertain affected infants. The systems were originally designed to detect potential 'epidemics' of birth defects that could occur following the widespread dissemination of new teratogens similar to thalidomide. In addition to monitoring, they have also proved to be useful resources for a variety of studies of the epidemiology of birth defects.
More Related Videos
Related Concept Videos
Standards of Care II
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity
Principles of Disease Surveillance

